Skip to main content
Signal8

Caligan Partners LP

SEC insider (Form 3/4/5 filer). CIK 0001727492. Insider at Verrica Pharmaceuticals Inc. (VRCA) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on May 19, 2026. Located in NEW YORK, NY.

Companies Caligan Partners LP has filed insider reports for

  • Verrica Pharmaceuticals Inc. (VRCA)
  • ALIMERA SCIENCES INC (ALIM): 10% Owner
  • Liquidia Corp (LQDA): Director, 10% Owner
Caligan Partners LP profile photo

Caligan Partners LP

CIK: 0001727492

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Verrica Pharmaceuticals Inc. logo
VRCA

Verrica Pharmaceuticals Inc.

ALIMERA SCIENCES INC logo
ALIM

ALIMERA SCIENCES INC

10% Owner
Liquidia Corp logo
LQDA

Liquidia Corp

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    May 19, 2026
    Sale
    Indirect
    5.3K shares at avg. $59.98$318K
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    May 19, 2026
    Purchase
    Indirect
    5.3K shares at avg. $59.98$318K
  • ALIMERA SCIENCES INC logo
    ALIM

    ALIMERA SCIENCES INC

    Sep 16, 2024
    Other
    Indirect
    16.8M shares-
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Sep 12, 2024
    Award
    Indirect
    1.1M shares at avg. $8.90$10.0M
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Aug 30, 2024
    Other
    Indirect
    3.4M shares-
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Aug 30, 2024
    Sale
    Indirect
    150K shares at avg. $9.51$1.4M
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Aug 30, 2024
    Purchase
    Indirect
    150K shares at avg. $9.51$1.4M

1-7 of 7